| - GRCh37:
- Chr1:55505511-55505737
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524211
- GRCh38:
- Chr1:55058538
| PCSK9 | S340W, S401W, S407W, S446W, S465W, S466W, S506W | Hypercholesterolemia, autosomal dominant, 3 | Likely pathogenic (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505624
- GRCh38:
- Chr1:55039951
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55521676
- GRCh38:
- Chr1:55056003
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518479
- GRCh38:
- Chr1:55052806
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505731-55505732
- GRCh38:
- Chr1:55040058-55040059
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523206
- GRCh38:
- Chr1:55057533
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55512328
- GRCh38:
- Chr1:55046655
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505726
- GRCh38:
- Chr1:55040053
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55512232
- GRCh38:
- Chr1:55046559
| PCSK9 | D21N, D187N, D82N, D146N | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524339-55524340
- GRCh38:
- Chr1:55058666-55058667
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55521861
- GRCh38:
- Chr1:55056188
| PCSK9 | E333G, E268G, E313G, E207G, E332G, E373G | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509593
- GRCh38:
- Chr1:55043920
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55525215
- GRCh38:
- Chr1:55059542
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505596
- GRCh38:
- Chr1:55039923
| PCSK9 | R29H | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55512237
- GRCh38:
- Chr1:55046564
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55525355
- GRCh38:
- Chr1:55059682
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505698
- GRCh38:
- Chr1:55040025
| PCSK9 | F64fs | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509717
- GRCh38:
- Chr1:55044044
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55521781
- GRCh38:
- Chr1:55056108
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518045
- GRCh38:
- Chr1:55052372
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505573-55505574
- GRCh38:
- Chr1:55039900-55039901
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505645
- GRCh38:
- Chr1:55039972
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509689
- GRCh38:
- Chr1:55044016
| PCSK9 | S168R, S127R, S2R | Hypercholesterolemia, autosomal dominant, 3 | Pathogenic (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55527043
- GRCh38:
- Chr1:55061370
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55529237
- GRCh38:
- Chr1:55063564
| PCSK9 | A562P, A668P, A728P, A688P, A520P, A629P, A687P, A623P, A701P | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523839
- GRCh38:
- Chr1:55058166
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55525174
- GRCh38:
- Chr1:55059501
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524166
- GRCh38:
- Chr1:55058493
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55529071
- GRCh38:
- Chr1:55063398
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55517973
- GRCh38:
- Chr1:55052300
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523096
- GRCh38:
- Chr1:55057423
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55517980
- GRCh38:
- Chr1:55052307
| PCSK9 | L226V, L121V, L166V, L185V, L60V | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509545
- GRCh38:
- Chr1:55043872
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524214
- GRCh38:
- Chr1:55058541
| PCSK9 | G466E, G408E, G402E, G467E, G341E, G447E, G507E | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Jul 30, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55518015
- GRCh38:
- Chr1:55052342
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505567
- GRCh38:
- Chr1:55039894
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Feb 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55512312
- GRCh38:
- Chr1:55046639
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype | Likely benign (Jul 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55523756
- GRCh38:
- Chr1:55058083
| PCSK9 | E410K, E346K, E391K, E285K, E411K, E451K | not specified, Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55529053
- GRCh38:
- Chr1:55063380
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jan 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509695
- GRCh38:
- Chr1:55044022
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Dec 25, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518364
- GRCh38:
- Chr1:55052691
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55525230
- GRCh38:
- Chr1:55059557
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jun 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524339-55524340
- GRCh38:
- Chr1:55058666-55058667
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518457
- GRCh38:
- Chr1:55052784
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Apr 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505531
- GRCh38:
- Chr1:55039858
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Nov 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524236
- GRCh38:
- Chr1:55058563
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Oct 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523740
- GRCh38:
- Chr1:55058067
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Feb 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518018
- GRCh38:
- Chr1:55052345
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype | Likely benign (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55524339-55524340
- GRCh38:
- Chr1:55058666-55058667
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524333
- GRCh38:
- Chr1:55058660
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jun 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524340-55524349
- GRCh38:
- Chr1:55058667-55058676
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518317
- GRCh38:
- Chr1:55052644
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Feb 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524340-55524345
- GRCh38:
- Chr1:55058667-55058672
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55525311
- GRCh38:
- Chr1:55059638
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 21, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505666
- GRCh38:
- Chr1:55039993
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Dec 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55527178
- GRCh38:
- Chr1:55061505
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524340-55524347
- GRCh38:
- Chr1:55058667-55058674
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505537
- GRCh38:
- Chr1:55039864
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype | Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55512332
- GRCh38:
- Chr1:55046659
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524269
- GRCh38:
- Chr1:55058596
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Nov 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523138
- GRCh38:
- Chr1:55057465
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518474
- GRCh38:
- Chr1:55052801
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505696
- GRCh38:
- Chr1:55040023
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55527249
- GRCh38:
- Chr1:55061576
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523165
- GRCh38:
- Chr1:55057492
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Sep 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55524156
- GRCh38:
- Chr1:55058483
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Benign (Nov 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509503
- GRCh38:
- Chr1:55043830
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518079
- GRCh38:
- Chr1:55052406
| PCSK9 | R218G, R199G, R259G, R93G, R154G | Hypercholesterolemia, autosomal dominant, 3 | Likely pathogenic (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523011
- GRCh38:
- Chr1:55057338
| PCSK9 | T335I, T316I, T376I, T210I, T336I, T271I | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55529244
- GRCh38:
- Chr1:55063571
| PCSK9 | Q689L, Q522L, Q564L, Q670L, Q730L, Q625L, Q631L, Q690L, Q703L | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505518
- GRCh38:
- Chr1:55039845
| PCSK9 | T3N | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55509659
- GRCh38:
- Chr1:55043986
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518382
- GRCh38:
- Chr1:55052709
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jul 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55518016
- GRCh38:
- Chr1:55052343
| PCSK9 | E197K, E133K, E72K, E238K, E178K | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523122
- GRCh38:
- Chr1:55057449
| PCSK9 | S372F, S308F, S353F, S413F, S247F, S373F | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55525327
- GRCh38:
- Chr1:55059654
| PCSK9 | V558I, V433I, V494I, V572I, V500I, V559I, V599I, V539I | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505713
- GRCh38:
- Chr1:55040040
| PCSK9 | A68V | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Sep 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518469
- GRCh38:
- Chr1:55052796
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55529060
- GRCh38:
- Chr1:55063387
| PCSK9 | E628K, E461K, E564K, E570K, E629K, E642K, E669K, E503K, E609K | Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55509624
- GRCh38:
- Chr1:55043951
| PCSK9 | G106R | Hypercholesterolemia, autosomal dominant, 3 | Conflicting interpretations of pathogenicity (Aug 7, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55523061
- GRCh38:
- Chr1:55057388
| PCSK9 | G352W, G227W, G353W, G288W, G333W, G393W | Hypercholesterolemia, autosomal dominant, 3 | Uncertain significance (Nov 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523137
- GRCh38:
- Chr1:55057464
| PCSK9 | T377N, T313N, T358N, T418N, T378N, T252N | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Oct 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55518321
- GRCh38:
- Chr1:55052648
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Feb 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55512197
- GRCh38:
- Chr1:55046524
| PCSK9 | A134D | Hypercholesterolemia, autosomal dominant, 3, Familial hypercholesterolemia | Uncertain significance (Jun 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55523851
- GRCh38:
- Chr1:55058178
| PCSK9 | | Cardiovascular phenotype, Familial hypercholesterolemia, Hypercholesterolemia, autosomal dominant, 3
| Conflicting interpretations of pathogenicity (Oct 16, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55527175
- GRCh38:
- Chr1:55061502
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jun 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55527049
- GRCh38:
- Chr1:55061376
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jul 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55517988
- GRCh38:
- Chr1:55052315
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3, Cardiovascular phenotype | Likely benign (Jun 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55527130
- GRCh38:
- Chr1:55061457
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Dec 5, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55524239
- GRCh38:
- Chr1:55058566
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505657
- GRCh38:
- Chr1:55039984
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Mar 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55512249
- GRCh38:
- Chr1:55046576
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Apr 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55523030
- GRCh38:
- Chr1:55057357
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55529084
- GRCh38:
- Chr1:55063411
| PCSK9 | S636R, S578R, S617R, S511R, S572R, S650R, S677R, S469R, S637R | Hypercholesterolemia, autosomal dominant, 3 | Likely pathogenic (May 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55505666
- GRCh38:
- Chr1:55039993
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55527052
- GRCh38:
- Chr1:55061379
| PCSK9 | | Cardiovascular phenotype, Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Aug 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55505606
- GRCh38:
- Chr1:55039933
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (May 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55523018
- GRCh38:
- Chr1:55057345
| PCSK9 | | Hypercholesterolemia, autosomal dominant, 3 | Likely benign (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55518427
- GRCh38:
- Chr1:55052754
| PCSK9 | | Cardiovascular phenotype, not provided, Hypercholesterolemia, autosomal dominant, 3
| Likely benign (Jan 1, 2022) | criteria provided, multiple submitters, no conflicts |